Simon Greenstone Panatier Bartlett lawyers are currently investigating serious bleeding incidents in the brain and gastrointestinal track linked to the use of Xarelto, an oral antiocoagulant drug prescribed to prevent blood clots. Unlike Warfarin, a trusted mainstay for preventing blood clots for the past 50 years, Xarelto does not have an antidote to stop uncontrolled bleeding, which can be fatal.
The Xarelto lawyers with Simon Greenstone Panatier Bartlett can be your advocate by helping you seek justice against Xarelto’s manufacturer, Janssen Pharmacueticals, a subsidiary of the well-known pharmacuetical manufacturer, Johnson & Johnson, and Xarelto’s co-marketer, Bayer HealthCare AG.
If you or a loved one experienced dangerous complications while using Xarelto, it is vital that you seek legal help immediately. To learn more, please contact our office today by calling 866-734-5291